Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Manu Sharma
Based on 38 articles published since 2008
||||
Expertise Level
The expertise of Manu Sharma ranks in the
  • Top 0.89%
  • ... of 69,482 published authors worldwide on Parkinson Disease
  • ... from 2008 through 2019
  • ... based on contributions to 38 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    University of Tubingen      
2018
  • Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tubingen, Tubingen, Germany. · Pubmed 29737560
2017
  • Department of Neurodegenerative Diseases, Center of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen and German Centre for Neurodegenerative Diseases, Tübingen, Germany. · Medical University Vienna, Department of Neurology, Vienna, Austria. · Department of Women's Health, Research Institute for Women's Health, University of Tübingen, Tübingen, Germany. · University of Tübingen, Interfaculty Institute of Biochemistry, Tübingen, Germany. · Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg. · Graduate Training Centre of Neuroscience, International Max Planck Research School, Tübingen, Germany. · University of Geneva, Department of Cell Biology, Geneva, Switzerland. · Department of Psychiatry and Psychotherapie, University Hospital Tübingen, Germany. · University of Tübingen, Interfaculty Institute for Cell Biology, Proteome Center Tübingen, Tübingen, Germany. · University of Tübingen, Interfaculty Institute of Cell Biology, Unit of Molecular Biology, Tübingen, Germany. · University of Tübingen, Institute of Medical Genetics and Applied Genomics, Tübingen, Germany. · MRC Toxicology Unit, University of Leicester, Leicester, UK. · Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB Stuttgart, Germany. · Department of Medicine/ Cardiology, CVRL, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Germany. · Parkinson Research Clinic, Centre Hospitalier de Luxembourg (CHL), Luxembourg. · Pubmed 29050400
  • Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands; Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA; Data Tecnica International, Glen Echo, MD, USA. · University California Irvine, Irvine, CA, USA. · Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands. · Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands; Netherlands Consortium for Healthy Ageing (NCHA), Rotterdam, the Netherlands; Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands. · MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, Wales, UK. · Inserm U1127, CNRS UMR7225, Sorbonne Universités, UPMC Univ Paris 06, UMR_S1127, Institut du Cerveau et de la Moelle épinière, Paris, France; Assistance Publique Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Reta Lila Weston Institute, University College London, London, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. Electronic address: · Pubmed 28867149
  • Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo2Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands4German Center for Neurodegenerative Diseases (DZNE), Tübingen. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo5Multimodal Imaging Laboratory, University of California at San Diego, La Jolla. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla6Department of Radiology and Biomedical Imaging, University of California, San Francisco. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland. · German Center for Neurodegenerative Diseases (DZNE), Tübingen. · Department of Psychiatry, University of California at San Diego, La Jolla9Department of Psychiatry, University of Copenhagen, Copenhagen, Denmark. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo10Department of Medical Genetics, University of Oslo, Oslo, Norway11Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla12Sciences Graduate Program, University of California at San Diego, La Jolla13Department of Neurosciences, University of California at San Diego, La Jolla. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo. · Institute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany. · Department of Medical Genetics, University of Oslo, Oslo, Norway11Department of Medical Genetics, Oslo University Hospital, Oslo, Norway15K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway16Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway17Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla15K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway. · K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway16Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway18Division of Gastroenterology, Institute of Medicine, University of Bergen, Bergen, Norway19Norwegian Primary Sclerosing Cholangitis (PSC) Research Center, Department of Transplantation Medicine, Oslo. · Sorbonne Universités, Université Pierre-et-Marie Curie (UPMC) Paris 06, UM 1127, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France21Institut National de la Santé et de la Récherche Médicale (INSERM), Unité 1127, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France22Centre National de la Recherche Scientifique (CNRS) UMR 7225, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France23Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France24Assistance Publique-Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Department of Clinical Neuroscience, National Hospital for Neurology and Neurosurgery (NHNN), University College London, London, England. · Department of Molecular Neurosciences, Institute of Neurology, University College London, London, England. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands4German Center for Neurodegenerative Diseases (DZNE), Tübingen27Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Rita Lila Weston Institute, University College London, London, England. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla8Department of Psychiatry, University of California at San Diego, La Jolla13Department of Neurosciences, University of California at San Diego, La Jolla29Department of Radiology, University of California at San Diego, La Jolla. · German Center for Neurodegenerative Diseases (DZNE), Tübingen27Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany30Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Pubmed 28586827
  • Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Institut du Cerveau et de la Moelle épinière, ICM, Inserm U 1127, CNRS, UMR 7225, Sorbonne Universités, UPMC University Paris 06, UMR S 1127, AP-HP, Pitié-Salpêtrière Hospital, Paris, France. · Departments of Neurology and Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Movement Disorders Unit, Department of Neurology, Hospital Universitari Mutua de Terrassa, Barcelona, Spain. · Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Barcelona, Spain; Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. · Department of Neurosciences, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon, Portugal. · Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. · Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands. · Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands; Netherlands Consortium for Healthy Ageing (NCHA), Rotterdam, the Netherlands. · Department of Neurosciences, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon, Portugal; Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands; Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands; Netherlands Consortium for Healthy Ageing (NCHA), Rotterdam, the Netherlands. · Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands; Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands; Netherlands Consortium for Healthy Ageing (NCHA), Rotterdam, the Netherlands. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. Electronic address: · Pubmed 27818000
  • Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tuebingen, Tuebingen, Germany. · Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL, USA. · Department of Neurology, St Olavs Hospital and NTNU, Trondheim, Norway. · Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy. · Neurology Department, Psychiatry Athens Hospital, Athens, Greece; 2nd Neurology Clinic, University of Athens, Attikon Hospital, Athens, Greece. · Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. · School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. · Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium; Department of Neurology, University Hospital Antwerp, Antwerp, Belgium. · Helmholtz Zentrum München, German Research Centre for Environmental Health (Gmbh), Neuherberg, Germany. · Department of Neurology, Cyclotron Research Centre, University of Liège, Liège, Belgium. · Department of Neurology, Faculty of Medicine, University of Thessaly and Institute of Biomedical Research and Technology, CERETETH, Larissa, Greece. · Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan. · Institute Department of Neurology, Seoul National University Hospital, Seoul, Korea. · ILSONG Institute of Life Science, Hallym University, Hallym Institute of Translational Genomics and Bioinformatics, Department of Neurology, Hallym University Sacred Heart Hospital, Gangwon, Korea. · Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. · INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France. · Department of Neurology, Chushang Show-Chwan Hospital, Nantou, Taiwan; Department of Neurology, Chung-Shan Medical University Hospital, Taichung, Taiwan. · The Dublin Neurological Institute at the Mater Misericordiae University Hospital, and Conway Institute, University College Dublin, Dublin, Ireland. · Eskitis Institute for Cell and Molecular Therapies, Griffith University, Queensland, Australia. · Therese Pei Fong Chow Research Center for Prevention of Dementia, Faculty of Medicine, The Chinese University of Hong Kong, Department of Medicine & Therapeutics, Clinical Neurology Research Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, New Territories, Hong Kong. · Faculty of Medicine, University of Southampton, Southampton, UK. · Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy; Department of Medical Sciences, Institute of Neurology, University Magna Graecia, Catanzaro, Italy. · Division of Neurology/Molecular Brain Science, Kobe University Graduate School of Medicine, Kobe, Japan. · University of Queensland Centre for Clinical Research, Herston, Australia. · 2nd Neurology Clinic, University of Athens, Attikon Hospital, Athens, Greece; Divisions of Basic Neurosciences and Cell Biology, Biomedical Research Foundation of Academy of Athens, Athens, Greece. · Neurosciences Department, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. · Department of Neurology, Singapore General Hospital, National Neuroscience Institute, Singapore; Programme in Neuroscience and Behavior Disorders, Duke-NUS Graduate Medical School, Durham, NC, USA. · Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium. · Department of Neurology, Mayo Clinic, Jacksonville, FL, USA. · Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden. · Department of Neurology, NorthShore University HealthSystem, Evanston, IL, USA. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Science Research, University of Tuebingen, Tuebingen, Germany. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Science Research, University of Tuebingen, Tuebingen, Germany; Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg City, Luxembourg; Centre Hospitalier de Luxembourg (CHL), Luxembourg City, Luxembourg. · Djavad Mowafhagian Centre for Brain, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA; School of Medicine and Medical Science, University College Dublin, Dublin, Ireland. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tuebingen, Tuebingen, Germany; Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Science Research, University of Tuebingen, Tuebingen, Germany. Electronic address: · Pubmed 27814993
2016
  • Department of Clinical Neuroscience, Institute of Neurology, University College London, London, UK. · Department of Psychological Medicine and Neurology, Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, UK. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK. · Department of Clinical Genetics, VU University Medical Center (VUmc), Amsterdam, The Netherlands. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Division of Life Science, Hong Kong University of Science and Technology, Hong Kong SAR, People's Republic of China. · School of Pharmacy, University of Reading, Whiteknights, Reading, UK. · Centre for Integrated Neuroscience and Neurodynamics, University of Reading, Whiteknights, Reading, UK. · Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, UK. · Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, Tübingen, Germany. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Division of Medicine, University College London, London, UK and 15UCL Genetics Institute, Department of Genetics, Environment and Evolution, University College London, London, UK. · Pubmed 27798102
  • Department for Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · German Centre of Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Werner Reichardt Centre for Integrative Neuroscience, Tübingen, Germany. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Division of Functional and Restorative Neurosurgery, University of Tübingen, Tübingen, Germany. · Clinical and Experimental Neuroscience, Luxembourg Center for Systems Biomedicine, University of Luxembourg, Luxembourg City, Luxembourg. · Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg. · Pubmed 26880248
2015
  • Authors' affiliations are listed at the end of the article. · Authors' affiliations are listed at the end of the article. · Pubmed 26354989
2014
  • 1] Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA. [2]. · 1] Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA. [2]. · 1] Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. [2] Department of Neurology, Focus Program Translational Neuroscience, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. · 23andMe, Inc., Mountain View, California, USA. · 1] Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA. [2] Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, UK. · 1] Department of Biostatistics, University of Washington, Seattle, Washington, USA. [2] INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France. [3] Paul Sabatier University, Toulouse, France. · 1] Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA. [2] Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA. [3] National Heart, Lung, and Blood Institute (NHLBI) Framingham Heart Study, Framingham, Massachusetts, USA. · Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK. · 1] Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. [2] Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA. · deCODE Genetics, Reykjavík, Iceland. · Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. · The Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA. · 1] Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. [2] Department of Radiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. [3] Department of Neurology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. · Stanford Prevention Research Center, Stanford University, Stanford, California, USA. · Neuroscience Unit, Department of Neurology, Faculty of Medicine, University of Thessaly, Larissa, Greece. · Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA. · 1] INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France. [2] Paul Sabatier University, Toulouse, France. · 1] Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, USA. [2] Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA. [3] Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA. · 1] Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, USA. [2] Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA. [3] Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA. [4] Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA. · 1] The Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA. [2] Gertrude H. Sergievsky Center, Columbia University Medical Center, New York, New York, USA. [3] Department of Neurology, Columbia University Medical Center, New York, New York, USA. [4] Department of Psychiatry, Columbia University Medical Center, New York, New York, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA. · Neuroscience Center, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA. · 1] Neuroscience Unit, Department of Neurology, Faculty of Medicine, University of Thessaly, Larissa, Greece. [2] Department of Neurology, Papageorgiou Hospital, Thessaloniki, Greece. · Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA. · 1] Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. [2] The Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA. · Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, UK. · Genome Biology for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Epidemiology Branch, National Institute of Environmental Health Sciences, US National Institutes of Health, Research Triangle, North Carolina, USA. · New York State Department of Health Wadsworth Center, Albany, New York, USA. · 1] Sorbonne Université, UPMC Université Paris 06, UM 75, INSERM U1127, Institut du Cerveau et de la Moelle, Paris, France. [2] CNRS, UMR 7225, Paris, France. [3] Pitié-Salpêtrière Hospital, Department of Genetics and Cytogenetics, Paris, France. · Department of Human Genetics, University of Miami School of Medicine, Miami, Florida, USA. · 1] Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. [2] School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK. · Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA. · Pubmed 25064009
  • Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, German Centre for Neurodegenerative Diseases (DZNE), Tübingen, Germany2Institute for Clinical Epidemiology and Applied Biometry, University of. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, German Centre for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Pubmed 24190229
2012
  • Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Pubmed 22786590
2011
  • Center of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tuebingen, Germany. · Pubmed 21782285
2009
  • Hertie-Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, University of Tuebingen, Hoppe-Seyler Strasse 3, 72076 Tuebingen, Germany. · Pubmed 18280617
2012
  • Center for Bioinformatics Tuebingen (ZBIT), University of Tuebingen, Tübingen, Germany. · Pubmed 22777693
2011
  • Laboratory of Functional Neurogenomics, Center of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Germany. · Pubmed 20036034
2009
  • Department for Neurodegenerative Diseases, Center of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, Germany. · Pubmed 19617636
Probable:    NewYork-Presbyterian Hospitals      
2018
  • Appel Institute for Alzheimer's Disease Research, Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York 10021. · Departments of Molecular and Cellular Physiology, Stanford University Medical School, Stanford, California 94305. · Howard Hughes Medical Institute, Stanford University Medical School, Stanford, California 94305. · Pubmed 28108534
Probable:    Cornell University      
2018
  • Appel Institute for Alzheimer's Disease Research, Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York 10021. · Departments of Molecular and Cellular Physiology, Stanford University Medical School, Stanford, California 94305. · Howard Hughes Medical Institute, Stanford University Medical School, Stanford, California 94305. · Pubmed 28108534
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 38 total) written by Manu Sharma about Parkinson Disease:

  • Cell Biology and Pathophysiology of α-Synuclein. 2018
  • Brain and gut: Partners in crime. 2018
  • Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease. 2017
  • Establishing the role of rare coding variants in known Parkinson's disease risk loci. 2017
  • Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases. 2017
  • Lack of evidence for a role of genetic variation in TMEM230 in the risk for Parkinson's disease in the Caucasian population. 2017
  • Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study. 2017
  • Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance. 2016
  • Mutation analyses and association studies to assess the role of the presenilin-associated rhomboid-like gene in Parkinson's disease. 2016
  • Alpha-synuclein gene variants may predict neurostimulation outcome. 2016
Show List of Full Article Records
Google Searches

Learn more about Manu Sharma using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Tubingen
NewYork-Presbyterian Hospitals
Cornell University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Tubingen
2018
  • Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tubingen, Tubingen, Germany. · Pubmed 29737560
2017
  • Department of Neurodegenerative Diseases, Center of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen and German Centre for Neurodegenerative Diseases, Tübingen, Germany. · Medical University Vienna, Department of Neurology, Vienna, Austria. · Department of Women's Health, Research Institute for Women's Health, University of Tübingen, Tübingen, Germany. · University of Tübingen, Interfaculty Institute of Biochemistry, Tübingen, Germany. · Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg. · Graduate Training Centre of Neuroscience, International Max Planck Research School, Tübingen, Germany. · University of Geneva, Department of Cell Biology, Geneva, Switzerland. · Department of Psychiatry and Psychotherapie, University Hospital Tübingen, Germany. · University of Tübingen, Interfaculty Institute for Cell Biology, Proteome Center Tübingen, Tübingen, Germany. · University of Tübingen, Interfaculty Institute of Cell Biology, Unit of Molecular Biology, Tübingen, Germany. · University of Tübingen, Institute of Medical Genetics and Applied Genomics, Tübingen, Germany. · MRC Toxicology Unit, University of Leicester, Leicester, UK. · Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB Stuttgart, Germany. · Department of Medicine/ Cardiology, CVRL, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Germany. · Parkinson Research Clinic, Centre Hospitalier de Luxembourg (CHL), Luxembourg. · Pubmed 29050400
  • Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands; Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA; Data Tecnica International, Glen Echo, MD, USA. · University California Irvine, Irvine, CA, USA. · Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands. · Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands; Netherlands Consortium for Healthy Ageing (NCHA), Rotterdam, the Netherlands; Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands. · MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, Wales, UK. · Inserm U1127, CNRS UMR7225, Sorbonne Universités, UPMC Univ Paris 06, UMR_S1127, Institut du Cerveau et de la Moelle épinière, Paris, France; Assistance Publique Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Reta Lila Weston Institute, University College London, London, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. Electronic address: · Pubmed 28867149
  • Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo2Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands4German Center for Neurodegenerative Diseases (DZNE), Tübingen. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo5Multimodal Imaging Laboratory, University of California at San Diego, La Jolla. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla6Department of Radiology and Biomedical Imaging, University of California, San Francisco. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland. · German Center for Neurodegenerative Diseases (DZNE), Tübingen. · Department of Psychiatry, University of California at San Diego, La Jolla9Department of Psychiatry, University of Copenhagen, Copenhagen, Denmark. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo10Department of Medical Genetics, University of Oslo, Oslo, Norway11Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla12Sciences Graduate Program, University of California at San Diego, La Jolla13Department of Neurosciences, University of California at San Diego, La Jolla. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo. · Institute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany. · Department of Medical Genetics, University of Oslo, Oslo, Norway11Department of Medical Genetics, Oslo University Hospital, Oslo, Norway15K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway16Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway17Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla15K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway. · K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway16Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway18Division of Gastroenterology, Institute of Medicine, University of Bergen, Bergen, Norway19Norwegian Primary Sclerosing Cholangitis (PSC) Research Center, Department of Transplantation Medicine, Oslo. · Sorbonne Universités, Université Pierre-et-Marie Curie (UPMC) Paris 06, UM 1127, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France21Institut National de la Santé et de la Récherche Médicale (INSERM), Unité 1127, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France22Centre National de la Recherche Scientifique (CNRS) UMR 7225, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France23Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France24Assistance Publique-Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Department of Clinical Neuroscience, National Hospital for Neurology and Neurosurgery (NHNN), University College London, London, England. · Department of Molecular Neurosciences, Institute of Neurology, University College London, London, England. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands4German Center for Neurodegenerative Diseases (DZNE), Tübingen27Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Rita Lila Weston Institute, University College London, London, England. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla8Department of Psychiatry, University of California at San Diego, La Jolla13Department of Neurosciences, University of California at San Diego, La Jolla29Department of Radiology, University of California at San Diego, La Jolla. · German Center for Neurodegenerative Diseases (DZNE), Tübingen27Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany30Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Pubmed 28586827
  • Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Institut du Cerveau et de la Moelle épinière, ICM, Inserm U 1127, CNRS, UMR 7225, Sorbonne Universités, UPMC University Paris 06, UMR S 1127, AP-HP, Pitié-Salpêtrière Hospital, Paris, France. · Departments of Neurology and Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Movement Disorders Unit, Department of Neurology, Hospital Universitari Mutua de Terrassa, Barcelona, Spain. · Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Barcelona, Spain; Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. · Department of Neurosciences, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon, Portugal. · Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. · Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands. · Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands; Netherlands Consortium for Healthy Ageing (NCHA), Rotterdam, the Netherlands. · Department of Neurosciences, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon, Portugal; Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands; Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands; Netherlands Consortium for Healthy Ageing (NCHA), Rotterdam, the Netherlands. · Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands; Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands; Netherlands Consortium for Healthy Ageing (NCHA), Rotterdam, the Netherlands. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. Electronic address: · Pubmed 27818000
  • Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tuebingen, Tuebingen, Germany. · Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL, USA. · Department of Neurology, St Olavs Hospital and NTNU, Trondheim, Norway. · Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy. · Neurology Department, Psychiatry Athens Hospital, Athens, Greece; 2nd Neurology Clinic, University of Athens, Attikon Hospital, Athens, Greece. · Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. · School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. · Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium; Department of Neurology, University Hospital Antwerp, Antwerp, Belgium. · Helmholtz Zentrum München, German Research Centre for Environmental Health (Gmbh), Neuherberg, Germany. · Department of Neurology, Cyclotron Research Centre, University of Liège, Liège, Belgium. · Department of Neurology, Faculty of Medicine, University of Thessaly and Institute of Biomedical Research and Technology, CERETETH, Larissa, Greece. · Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan. · Institute Department of Neurology, Seoul National University Hospital, Seoul, Korea. · ILSONG Institute of Life Science, Hallym University, Hallym Institute of Translational Genomics and Bioinformatics, Department of Neurology, Hallym University Sacred Heart Hospital, Gangwon, Korea. · Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. · INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France. · Department of Neurology, Chushang Show-Chwan Hospital, Nantou, Taiwan; Department of Neurology, Chung-Shan Medical University Hospital, Taichung, Taiwan. · The Dublin Neurological Institute at the Mater Misericordiae University Hospital, and Conway Institute, University College Dublin, Dublin, Ireland. · Eskitis Institute for Cell and Molecular Therapies, Griffith University, Queensland, Australia. · Therese Pei Fong Chow Research Center for Prevention of Dementia, Faculty of Medicine, The Chinese University of Hong Kong, Department of Medicine & Therapeutics, Clinical Neurology Research Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, New Territories, Hong Kong. · Faculty of Medicine, University of Southampton, Southampton, UK. · Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy; Department of Medical Sciences, Institute of Neurology, University Magna Graecia, Catanzaro, Italy. · Division of Neurology/Molecular Brain Science, Kobe University Graduate School of Medicine, Kobe, Japan. · University of Queensland Centre for Clinical Research, Herston, Australia. · 2nd Neurology Clinic, University of Athens, Attikon Hospital, Athens, Greece; Divisions of Basic Neurosciences and Cell Biology, Biomedical Research Foundation of Academy of Athens, Athens, Greece. · Neurosciences Department, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. · Department of Neurology, Singapore General Hospital, National Neuroscience Institute, Singapore; Programme in Neuroscience and Behavior Disorders, Duke-NUS Graduate Medical School, Durham, NC, USA. · Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium. · Department of Neurology, Mayo Clinic, Jacksonville, FL, USA. · Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden. · Department of Neurology, NorthShore University HealthSystem, Evanston, IL, USA. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Science Research, University of Tuebingen, Tuebingen, Germany. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Science Research, University of Tuebingen, Tuebingen, Germany; Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg City, Luxembourg; Centre Hospitalier de Luxembourg (CHL), Luxembourg City, Luxembourg. · Djavad Mowafhagian Centre for Brain, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA; School of Medicine and Medical Science, University College Dublin, Dublin, Ireland. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tuebingen, Tuebingen, Germany; Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Science Research, University of Tuebingen, Tuebingen, Germany. Electronic address: · Pubmed 27814993
2016
  • Department of Clinical Neuroscience, Institute of Neurology, University College London, London, UK. · Department of Psychological Medicine and Neurology, Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, UK. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK. · Department of Clinical Genetics, VU University Medical Center (VUmc), Amsterdam, The Netherlands. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Division of Life Science, Hong Kong University of Science and Technology, Hong Kong SAR, People's Republic of China. · School of Pharmacy, University of Reading, Whiteknights, Reading, UK. · Centre for Integrated Neuroscience and Neurodynamics, University of Reading, Whiteknights, Reading, UK. · Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, UK. · Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, Tübingen, Germany. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Division of Medicine, University College London, London, UK and 15UCL Genetics Institute, Department of Genetics, Environment and Evolution, University College London, London, UK. · Pubmed 27798102
  • Department for Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · German Centre of Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Werner Reichardt Centre for Integrative Neuroscience, Tübingen, Germany. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany. · Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Division of Functional and Restorative Neurosurgery, University of Tübingen, Tübingen, Germany. · Clinical and Experimental Neuroscience, Luxembourg Center for Systems Biomedicine, University of Luxembourg, Luxembourg City, Luxembourg. · Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg. · Pubmed 26880248
2015
  • Authors' affiliations are listed at the end of the article. · Authors' affiliations are listed at the end of the article. · Pubmed 26354989
2014
  • 1] Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA. [2]. · 1] Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA. [2]. · 1] Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. [2] Department of Neurology, Focus Program Translational Neuroscience, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. · 23andMe, Inc., Mountain View, California, USA. · 1] Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA. [2] Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, UK. · 1] Department of Biostatistics, University of Washington, Seattle, Washington, USA. [2] INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France. [3] Paul Sabatier University, Toulouse, France. · 1] Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA. [2] Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA. [3] National Heart, Lung, and Blood Institute (NHLBI) Framingham Heart Study, Framingham, Massachusetts, USA. · Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK. · 1] Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. [2] Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA. · deCODE Genetics, Reykjavík, Iceland. · Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. · The Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA. · 1] Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. [2] Department of Radiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. [3] Department of Neurology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. · Stanford Prevention Research Center, Stanford University, Stanford, California, USA. · Neuroscience Unit, Department of Neurology, Faculty of Medicine, University of Thessaly, Larissa, Greece. · Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA. · 1] INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France. [2] Paul Sabatier University, Toulouse, France. · 1] Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, USA. [2] Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA. [3] Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA. · 1] Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, USA. [2] Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA. [3] Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA. [4] Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA. · 1] The Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA. [2] Gertrude H. Sergievsky Center, Columbia University Medical Center, New York, New York, USA. [3] Department of Neurology, Columbia University Medical Center, New York, New York, USA. [4] Department of Psychiatry, Columbia University Medical Center, New York, New York, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA. · Neuroscience Center, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA. · 1] Neuroscience Unit, Department of Neurology, Faculty of Medicine, University of Thessaly, Larissa, Greece. [2] Department of Neurology, Papageorgiou Hospital, Thessaloniki, Greece. · Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA. · 1] Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. [2] The Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA. · Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, UK. · Genome Biology for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Epidemiology Branch, National Institute of Environmental Health Sciences, US National Institutes of Health, Research Triangle, North Carolina, USA. · New York State Department of Health Wadsworth Center, Albany, New York, USA. · 1] Sorbonne Université, UPMC Université Paris 06, UM 75, INSERM U1127, Institut du Cerveau et de la Moelle, Paris, France. [2] CNRS, UMR 7225, Paris, France. [3] Pitié-Salpêtrière Hospital, Department of Genetics and Cytogenetics, Paris, France. · Department of Human Genetics, University of Miami School of Medicine, Miami, Florida, USA. · 1] Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. [2] School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK. · Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA. · Pubmed 25064009
  • Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, German Centre for Neurodegenerative Diseases (DZNE), Tübingen, Germany2Institute for Clinical Epidemiology and Applied Biometry, University of. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, German Centre for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Pubmed 24190229
2012
  • Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Pubmed 22786590
2011
  • Center of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tuebingen, Germany. · Pubmed 21782285
2009
  • Hertie-Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, University of Tuebingen, Hoppe-Seyler Strasse 3, 72076 Tuebingen, Germany. · Pubmed 18280617
2012
  • Center for Bioinformatics Tuebingen (ZBIT), University of Tuebingen, Tübingen, Germany. · Pubmed 22777693
2011
  • Laboratory of Functional Neurogenomics, Center of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Germany. · Pubmed 20036034
2009
  • Department for Neurodegenerative Diseases, Center of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, Germany. · Pubmed 19617636
NewYork-Presbyterian Hospitals
2018
  • Appel Institute for Alzheimer's Disease Research, Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York 10021. · Departments of Molecular and Cellular Physiology, Stanford University Medical School, Stanford, California 94305. · Howard Hughes Medical Institute, Stanford University Medical School, Stanford, California 94305. · Pubmed 28108534
Cornell University
2018
  • Appel Institute for Alzheimer's Disease Research, Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York 10021. · Departments of Molecular and Cellular Physiology, Stanford University Medical School, Stanford, California 94305. · Howard Hughes Medical Institute, Stanford University Medical School, Stanford, California 94305. · Pubmed 28108534
University College London
2016
  • Department of Clinical Neuroscience, Institute of Neurology, University College London, London, United Kingdom. · Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Center for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Neurology, Cardiff University School of Medicine, Cardiff, United Kingdom. · Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Université Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany and Genome Biology for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom. · Reta Lila Weston Institute, University College London Institute of Neurology, London, United Kingdom. · Genome Biology for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · UCL Genetics Institute, University College London, London, United Kingdom. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD. · Pubmed 26389967
2013
  • Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, United Kingdom. · Pubmed 23967090
  • Department of Psychological Medicine and Neurology, Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre in Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff CF14 4XN, UK. · Pubmed 23223016
Miscellaneous institutions in Tubingen
2016
  • Department of Clinical Neuroscience, Institute of Neurology, University College London, London, UK. · Department of Psychological Medicine and Neurology, Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, UK. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK. · Department of Clinical Genetics, VU University Medical Center (VUmc), Amsterdam, The Netherlands. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Division of Life Science, Hong Kong University of Science and Technology, Hong Kong SAR, People's Republic of China. · School of Pharmacy, University of Reading, Whiteknights, Reading, UK. · Centre for Integrated Neuroscience and Neurodynamics, University of Reading, Whiteknights, Reading, UK. · Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, UK. · Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, Tübingen, Germany. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Division of Medicine, University College London, London, UK and 15UCL Genetics Institute, Department of Genetics, Environment and Evolution, University College London, London, UK. · Pubmed 27798102
  • Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, Tübingen, Germany; Department of Psychiatry and Psychotherapie, University Hospital Tübingen, Germany. Electronic address: · Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Department of Neurology, St Josef-Hospital, Ruhr-University Bochum, Bochum, Germany; Department of Neurology, Katholische Kliniken Ruhrhalbinsel GmbH, Essen. · Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany; Clinical and Experimental Neurology, Luxembourg Center for Systems Biomedicine, University of Luxembourg, Luxembourg; Centre Hospitalier de Luxembourg, Luxembourg. Electronic address: · Pubmed 26778534
2012
  • Department. of Neurodegenerative diseases, Hertie-Institute for Clinical Brain Research and DZNE- German Center for Neurodegenerative Diseases, Tübingen, Hoppe-Seyler-Str. 3, Tübingen 72076, Germany. · Pubmed 23125461
2010
  • DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Pubmed 20817635
Unspecified
2014
  • Authors' affiliations are listed at the end of the article. · Authors' affiliations are listed at the end of the article. · Pubmed 25326098
Stanford University
2012
  • Department of Molecular and Cellular Physiology, and Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305-5453, USA. · Pubmed 22896677
2012
  • Department of Molecular and Cellular Physiology, Stanford University, Stanford, California 94305-5453, USA. · Pubmed 23100443
8 Other Locations Show
Yearly article counts 025414475240
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.